Stay updated on Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page’s UI/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3.”SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check44 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. This appears to be a system/version update rather than a modification to the study content.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.4.2 updated from v3.4.1; no visible changes to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedA minor software revision update was made from v3.4.0 to v3.4.1; there are no observable changes to study content, structure, or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.